Skin manifestations of secondary dyslipidemia: a case report
https://doi.org/10.15829/1560-4071-2022-5133
Abstract
In the presented case report, 27-year-old female patient consulted a dermatologist and a lipidologist due to the appearance of small red spots on the skin. At the stage of examination in the lipid center, the patient was diagnosed with diabetes. During additional examination in the department of endocrinology, the following diagnosis was made: "Newlu-diagnosed type 1 diabetes. Target glycated hemoglobin level 6,5%. Secondary dyslipidemia. Skin xanthomatosis". After the start of therapy, laboratory parameters improved and the number of eruptive xanthomas decreased. Eruptive xanthomatosis in clinical practice is rare, and requires apprehensive attitude of doctors of various specialties. Timely detection of lipid metabolism disorders allows patients to recommend not only rational measures to prevent the development and progression of atherosclerosis, but also to diagnose the causes of secondary dyslipidemia.
About the Authors
Z. F. Kim
Kazan State Medical University;
City Clinical Hospital № 7
Kazan
A. S. Galyavich
Kazan State Medical University
Kazan
I. M. Nurieva
Kazan State Medical University;
City Clinical Hospital № 7
Kazan
N. I. Bayazova
City Clinical Hospital № 7
Kazan
References
1. Ishevskaia OP, Namitokov AM, Kruchinova SV, et al. Familial hypercholesterolemia: case series of a rare condition. Russian Journal of Cardiology. 2021;26(3S):4610. (In Russ.) doi:10.15829/1560-4071-2021-4610.
2. Surkichin SI, Gryazeva NV. Eyelid xanthelasma and its management. Medical alphabet. 2019;1(7):63-4. (In Russ.) doi:10.33667/2078-5631-2019-1-7(382)-63-64.
3. Pankratov VG. Xanthomatosis of the skin and mucous membranes as a manifestation of dyslipidemia. Meditsinskie novosti. 2014;6:15-20. (In Russ.)
4. Kukharchuk VV, Ezhov MV, Sergienko IV, et al. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat of atherosclerosis Russian recommendations VII revision. Аtherosclerosis and dyslipidemia. 2020;1(38):7-41. doi:10.34687/2219-8202.JAD.2020.01.0002.
5. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Russian Journal of Cardiology. 2020;25(5):3826. (In Russ.) doi:10.15829/1560-4071-2020-3826.
6. Virani S, Morris P, Agarwala A, et al. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia. J Am Coll Cardiol. 2021;78(9):960-93. doi:10.1016/j.jacc.2021.06.011.
Supplementary files
Review
For citations:
Kim Z.F., Galyavich A.S., Nurieva I.M., Bayazova N.I. Skin manifestations of secondary dyslipidemia: a case report. Russian Journal of Cardiology. 2022;27(9):5133. (In Russ.) https://doi.org/10.15829/1560-4071-2022-5133
Views:
2736
Email this article 